transfusion are the keynotes to successful anxsthesia in patients with any of the sickling states. Tourniquets should always be exsanguinating and surgery rapid and expert.
Postoperative Management A recovery ward where expert detailed supervision and blood gas analysis can be carried out should be available. Oxygen should be used for the first 24 hours and there should be no hesitation in using artificial ventilation whenever there is the slightest respiratory inadequacy. Circulatory stasis and cooling should always be avoided.
Conclusion
The balance of opinion at the present time would seem to indicate that complex methods ofmanagement based on theoretical considerations do not appear to offer any proven practical advantages over the simple commonsense measures that any anasthetist would automatically adopt to counteract the natural characteristics of the disease. 
Management of Sickle Cell Disorders
With the increase in the immigrant population the management of sickling disorders is no longer an uncommon problem within these shores. In people of African descent the carrier or trait form has an incidence of approximately 1 in 10 and the disease occurs in approximately 1 in 400; the sickle gene occurs sporadically in people from the Mediterranean and Middle East areas.
The advances in knowledge from both electron microscopy and X-ray crystallography have increased our knowledge of the molecular events causing the cells to sickle. Ms a result of the substitution of glycine by valine in the sixth residue of the f-chain the sickle haemoglobin molecules aggregate in a regular geometric pattern to form tactoids when the molecule is deoxygenated (Perutz 1970) . Such aggregation does not occur in the oxygenated state. The tactoid formation distorts the red cell into the rigid well known sickle cell predisposing it to sludge in the small vessels, leading to microinfarcts and to the cell's own premature destruction and hmmolysis. From this brief description of the molecular and cellular events of the sickling phenomenon, factors which tend to cause deoxygenation of the hemoglobin molecule would be expected to predispose to the sickling phenomenon; for clinical purposes these are hypoxia, acidosis and fever. Coupled with these factors is dehydration which, by causing stagnation of blood, predisposes to sludging in vessels as well as localized hypoxia and acidosis which all contribute to establishing a crisis.
Management
In managing patients with sickle hemoglobin it is first important to differentiate those who have the trait form and hence are usually symptom-free from those who have a sickle cell syndrome (this includes homozygous sickle cell disease, hemoglobin SC disease and sickle cell / thalasswmia).
As the commonly performed solubility test (Sickledex) only indicates the presence of sickle hemoglobin it does not reliably differentiate between these conditions. The various sickle cell syndromes are characterized by a raised reticulocyte count under normal conditions as distinct from the trait condition in which there is not a continuing hemolytic state (Table 1) . It should be noted that a normal or near normal hmmoglobin concentration does not necessarily signify a milder condition or that the patient has the trait condition; this particularly applies to hemoglobin SC disease where the haemoglobin is often within the normal range. These three simple tests can therefore be used as a guideline for management, particularly in emergency situations where further identification by hiemoglobin electrophoresis may not be possible. The finding of a reduced mean cell volume and mean cell hemoglobin strongly suggests sickle cell thalassamia disease. It is important not to confuse sickle cell fi thalassemia with iron deficiency in sickle cell trait, although in the latter case the reticulocyte count is not raised and the fraction of haemoglobin A on electrophoresis is higher. These investigations therefore allow patients to be categorized into two broad groups for consideration of management: sickle cell trait and sickle cell syndromes.
Sickle Cell Trait Perhaps one of the most important aspects of management is adequate explanation of the carrier state with reassurance of its general innocuous nature. Provided the age and circumstances of the patient are suitable genetic counselling should be undertaken and the risks of having children afflicted by sickle cell disease explained. Although the risk from hypoxia is less than the risk in sickle cell syndromes there is little doubt that anasthesia may be a hazard and the patient should be told to inform the anasthetist should general anmsthesia be considered. The management of the anesthetic should be to avoid hypoxia, acidosis or dehydration occurring. Furthermore, under anesthesia normal temperature regulation is lost and it would seem wise to ensure that body temperature does not alter significantly. In the postoperative period when perhaps vigilance might lapse it is essential to ensure that hypoxia does not occur and that patients are carefully supervised until fully ,conscious and able to maintain their airway. Hypoxia from other sources is unlikely except from exposure to altitude and cases of crises in the trait form have been recorded at 10000 ft (3000 m) and ascent above this height is probably not advised. Flight in standard commercial aircraft, pressurized at 5000-7000 ft (1500-2100 m), does not appear to be contraindicated although in the rare event of loss of pressurization these people would be at greater risk.
Sickle Cell Syndromes
The problem of management is twofold, first the avoidance of crises and then the treatment of established crises. The prophylactic management consists of protecting the patient from the factors, listed above, known to precipitate crises. Infective illness must be treated promptly to reduce fever and the use of an antipyretic such as aspirin has much to commend it in this respect. In areas where malaria is prevalent the use of prophylactic antimalarials has been shown to reduce the incidence of crises (Warley et al. 1965 ).
On similar grounds the use of prophylactic antibiotics in patients, such as school children, subject to recurrent upper respiratory infections might be considered beneficial although there appear to be no conclusive data on this fact. In the presence of fever it is equally important to avoid both acidosis and dehydration by ensuring adequate food and fluid intake. It is interesting that with increasing age there is a progressive loss in concentration ability by the kidney in sickle cell disease, hence these patients have a particular propensity to become dehydrated (Hatch et al. 1967) .
In avoiding hypoxia the commonest clinical problem is again the request for advice regarding flying. On this subject the literature is largely anecdotal and gives no clear conclusions but undoubtedly the occasional patient does suffer from a crisis as a result of travelling in standard pressurized aircraft. The risk is probably very small and with suitable explanation most patients opt to fly. In clinical practice hypoxia may occur as a result of pneumonia and increasing the oxygen tension of the inspired air in these conditions is recommended. The continuing haemolytic state results in an increased requirement for folic acid and deficiency has been recorded leading to increase in the anmemia. It is common practice to recommend that these patients take folic acid supplements although in the UK it would seem unlikely that it will be required if the diet is normal.
The operative management of the sickle cell syndromes requires particular care. As well as the precautions of the anesthetic outlined above in discussing the trait condition it is also advisable to transfuse the patient preoperatively. This has two primary objects: to reduce the anxmia and to reduce the chance of a crisis by diluting cells able to sickle with normal cells. A suitable programme in an adult is to transfuse 3-4 units of blood four weeks and again one week prior to operation. At operation the blood will thus contain approximately 50 % transfused red cells. Such a transfusion regime is recommended in the last trimester of pregnancy. In the face of an intended emergency operation such preparation is not feasible and it must be emphasized that it is usually better not to delay the operation, paiticularly if the underlying condition is likely to precipitate a crisis, though nothing but good can come from starting transfusion while the operation is under way. The use of tourniquets on patients with either the trait or sickle cell syndromes is a potential hazard, although from case reports it would seem that provided an exsanguinating tourniqu4et is used little harm ensues. Presumably insufficient cells remain in the limb to block vessels and initiate a crisis and in any case they are flushed out in the hyperemia that follows release of the tourniquet.
Although many specific agents have been suggested for the treatment of an established crisis none has stood the test of time. Even the recent encouraging initial reports of intravenous urea have not been substantiated by further clinical trials (Kraus 1973) . Frequently crises are are precipitated by infections and a search for and treatment of these is essential so that the period of fever is reduced to a minimum. Likewise maintenance of hydration and correction of acidosis is equally important and usually best accomplished by intravenous therapy using isotonic saline and sodium bicarbonate, but the use of an induced alkalosis by this means has not proved beneficial (Hugh Jones et al. 1964) .
Recent reports of the antisickling effect of cyanate are encouraging as this represents a drug inhibiting the sickling process at the molecular level (Cerami & Manning 1971) . The cyanate binds to the hkmoglobin and acts by increasing the oxygen affinity and hence at any given oxygen tension it is more saturated with oxygen and less likely to sickle. However, under complete deoxygenation the sickling phenomenon still occurs. Early clinical trials of long-term oral administration are encouraging in that the incidence of crises appears to be reduced and toxic effects have not been excessive (Peterson et al. 1974) . The result of further double-blind trials and toxicology studies are awaited with interest.
In conclusion, the vaiious sickling conditions provide a challenging group of diseases to manage. The mainstay of treatment at present is avoiding those physiological disturbances which predispose to the sickling process but with the advent of cyanate further, more specific drugs might be expected. This must be coupled with considerable social support and genetic counselling as there is frequently alarm and misunderstanding surrounding sickle cell disease. Education of the community is valuable and considerable encouragement must be given to employers and insurance companies to be certain that these patients do not become the 'lepers' of the twentieth century. The difficulty of treating non-union of carpal scaphoid fractures and Preiser's scaphoid necrosis is well-known, and is reflected in the variety of procedures recommended (Agner 1963 , Boyd 1971 . Replacement of the scaphoid with vitallium prostheses was introduced in 1942 with encouraging early results (Waugh & Reuling 1945) . The results of replacement with acrylic prostheses were considered satisfactory in 14 of 16 wrists after a period of up to eight years (Agerholm & Lee 1966), but Agner (1963), reporting a different technique, found only 1 wrist out of 7 to be satisfactory 9 to 11 years after acrylic replacement. Swanson (1970) has reported good early results with scaphoid prostheses of silicone rubber.
The purpose of this paper is to report the longterm (nine to nineteen years) assessment of acrylic prosthetic replacement of the scaphoid, as introduced in Oxford by the late J C Agerholm.
Technique
The prostheses were manufactured from methylmethacrylate, in a range of sizes, in moulds taken from cadaveric bones. The operative technique has been described by Agerholm & Lee (1966) .
Material
Sixteen patients had acrylic scaphoid prostheses inserted at the Nuffield Orthopedic Centre between 1954 and 1963 (Table 1) . These were patients with either old ununited fractures and osteoarthritic changes sufficient for the patient to accept arthrodesis of the wrist, or more recent fractures with avascular necrosis of the proximal fragment. Ten of these patients, with their prostheses still in situ, were available for followup examination. One patient (GF) had bilateral replacementsso the review is of 11 prostheses in 10 patients.
All patients were physically active males with no other significant pathology. Ages ranged from 26 to 61 at the time of operation. In 10 of the wrists the symptoms were associated with nonunion of a scaphoid fracture; the remaining patient (WF) was considered to have Preiser's
